• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0 W/SA2.0 20 & DISTAL CATHETER; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0 W/SA2.0 20 & DISTAL CATHETER; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX648T
Device Problem Infusion or Flow Problem (2964)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 01/31/2020
Event Type  Injury  
Manufacturer Narrative
Height: 193 cm.When additional information becomes available a follow up report will be submitted.
 
Event Description
It was reported that there is an issue with a valve.The reporter indicated that a 2 month 11 day post-operative valve malfunctioned.The device was explanted.Additional event details have not provided, however, have been requested.
 
Manufacturer Narrative
Visual inspection: in the first step of our investigations, an optical control is carried out.It is checked whether any defects, deformations or other noticeable irregularities can be identified.Permeability test: to proof the penetrability of the valves we have carried out penetrability tests.These tests are carried out at a calculated hydrostatic high (open pressure of the valves + 30 cmh2o) in horizontal direction of flow.Computer controlled test: to investigate the claim of under-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus, which simulates a cerebrospinal fluid flow.The valves are tested by simulating a cerebrospinal fluid flow at rates between 60 ml/h down to 5 ml/h and up again to 60 ml/h with the valves in both vertical position and horizontal position (in acc.To iso 7197).Distilled water is used as the test-liquid.Adjustment test: the adjustment test is used to ensure that the proga_v 2.0 can be adjusted to all pressure levels.The tests are carried out with the standard progav 2.0 checkmate and measurement tool.The valve is adjusted from 0 to 20 cmh2o and down again in increments of 5 cmh2o.Braking force and brake function test: to measure the braking force, we tested the progav 2.0 valve with a braking force apparatus.Here it is measured how much force must be exerted on the housing to release the rotor to adjust the valve by the integrated magnet of the braking force apparatus.Results: it should be noted that the shunt system was received dry (i.E.Not submersed in liquid as recommended).The investigation of dry items is not significant due to the affect dry deposits of liquor and blood can have on product performance.In spite of this, we have investigated the system to the best of our abilities.No significant deformations or damage of the valves were detected during the visual inspection.Next, we tested the permeability and opening pressure of the valves.Both valves were shown to be permeable and their opening pressures were operating within specifications.Additionally, we tested the adjustability as well as the brake functionality and brake force of the progav 2.0 valve.The valve operated as expected and met all specifications.Finally, we have dismantled the progav 2.0.The shunt assistant 2.0 was not dismantled because there was no reason for complaint and no deviations in the product could be observed during the investigation.There were no visible deposits observed inside the progav 2.0.Based on our investigation, we are unable to substantiate the claim of under-drainage and non-adjustability.At the time of our investigation, the progav 2.0 was able to be adjusted to all specified settings and operates to all specified tolerances.At the time of the investigation we are not able to determine how the functional impairment mentioned above occurred in the past.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV 2.0 W/SA2.0 20 & DISTAL CATHETER
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key9744381
MDR Text Key186105360
Report Number3004721439-2020-00050
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K190174
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 03/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/12/2024
Device Model NumberFX648T
Device Catalogue NumberFX648T
Device Lot Number20042407
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/05/2020
Initial Date Manufacturer Received 02/05/2020
Initial Date FDA Received02/24/2020
Supplement Dates Manufacturer Received03/04/2020
Supplement Dates FDA Received03/04/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age49 YR
Patient Weight115
-
-